Cork biotech firm secures $300 million funding for budget mRNA vaccine facilities

Normax Biomed is aiming to develop modular vax factories globally. The first one, planned for Cork, will employ around 200 people

Peter A Jensen, chief executive and chairman of Normax: founded the company in 2020

Normax Biomed, an Irish-headquartered biotechnology company, has secured a €300 million funding commitment to develop low-cost mRNA vaccines for a wide array of diseases.

The firm plans to open facilities globally. The first will be based in Cork, where it intends to develop a €30 million manufacturing plant that will lead to the creation of 200 jobs.

The financing comes ahead of a planned initial public offering (IPO) with a dual listing on the London ...